Ecallantide for the treatment of acute attacks in hereditary angioedema

M Cicardi, RJ Levy, DL McNeil, HH Li… - … England Journal of …, 2010 - Mass Medical Soc
Background Hereditary angioedema is a rare genetic disorder characterized by acute,
intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We …

Ecallantide for the treatment of acute attacks in hereditary angioedema

M Cicardi, RJ Levy, DL McNeil… - The New England …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Hereditary angioedema is a rare genetic disorder characterized by acute,
intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We …

Ecallantide for the treatment of acute attacks in hereditary angioedema

M Cicardi, RJ Levy, DL Mcneil, L HH… - NEW ENGLAND …, 2010 - air.unimi.it
BACKGROUND Hereditary angioedema is a rare genetic disorder characterized by acute,
intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We …

EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

RJ Levy, WR Lumry, DL McNeil, HH Li… - Annals of Allergy …, 2010 - annallergy.org
Background Hereditary angioedema (HAE) is a genetic disorder resulting from low levels of
C1-inhibitor activity that manifests as acute attacks of variable and sometimes life …

Ecallantide for the treatment of acute attacks in hereditary angioedema

M Cicardi, RJ Levy, DL McNeil, HH Li… - … England Journal of …, 2010 - pure.johnshopkins.edu
Background: Hereditary angioedema is a rare genetic disorder characterized by acute,
intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We …

[PDF][PDF] Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema

M Cicardi, RJ Levy, DL McNeil, HH Li, AL Sheffer… - N Engl J …, 2010 - researchgate.net
Background Hereditary angioedema is a rare genetic disorder characterized by acute,
intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We …

[引用][C] EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

RJ LEVY, WR LUMRY, DL MCNEIL… - Annals of allergy …, 2010 - pascal-francis.inist.fr
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute
attacks of hereditary angioedema CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[PDF][PDF] Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema

M Cicardi, RJ Levy, DL McNeil, HH Li, AL Sheffer… - N Engl J Med, 2010 - Citeseer
Background Hereditary angioedema is a rare genetic disorder characterized by acute,
intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We …

[引用][C] EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

RJ Levy, WR Lumry, DL McNeil, HH Li… - Annals of Allergy …, 2010 - cir.nii.ac.jp
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute
attacks of hereditary angioedema | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

RJ Levy, WR Lumry, DL McNeil, HH Li… - Annals of Allergy …, 2010 - infona.pl
Hereditary angioedema (HAE) is a genetic disorder resulting from low levels of C1-inhibitor
activity that manifests as acute attacks of variable and sometimes life-threatening edema …